Marlborough-based IQuum Inc. today said it has gained approval from the U.S. Food and Drug Administration to enable laboratory use of its Liat Influenza A/2009 H1N1 Assay in identifying and differentiating H1N1 flu virus samples within 30 minutes.Last year, IQuum was awarded $1.1 million in National Institutes of Health funds to develop a test to [...]
Read the full article →
We compared the QuickVue Influenza Test with PCR for diagnosing pandemic (H1N1) 2009 in 404 persons with influenza-like illness. Overall sensitivity, specificity, and positive and negative predictive values were 66%, 84%, 84%, and 64%, respectively. Rapid test results should be interpreted cautiously when pandemic (H1N1) 2009 virus is suspected. via A TIME’S MEMORY: Rapid Influenza [...]
Read the full article →